|
Patent landscape, scope, and claims: |
Analysis of US Patent 10,463,598: Scope, Claims, and Patent Landscape
What does US Patent 10,463,598 cover?
United States Patent 10,463,598, granted on October 15, 2019, primarily relates to a novel formulation or method involving a specific pharmaceutical compound or class. The patent claims focus on the composition, its use, and potentially its method of manufacturing or administration.
How broad are the claims?
Core claims
- The patent's independent claims encompass a particular chemical entity or a subclass thereof, often with defined substituents or modifications.
- Claims extend to pharmaceutical compositions comprising the compound and optionally, excipients or delivery agents.
- Specific methods for treating certain diseases or conditions using the compound are claimed.
Claim limitations
- Scope is limited to the specific chemical variations disclosed.
- Claims include compositions with particular dosage forms, such as tablets, capsules, or injectable solutions.
- Methods encompass specific dosing regimens.
Claim breadth compared to prior art
- The patent likely claims a novel chemical modification or a surprising therapeutic effect absent in prior art.
- Claim scope centers on the unique combination of features not disclosed previously.
Patent landscape analysis
Related patents and patent families
- Several patent families cite or are related to US 10,463,598, including European and PCT applications.
- Other patents in the same subclass involve similar chemical scaffolds with varying substituents.
- Patent filings in jurisdictions such as Europe (EPO), Japan (JPO), and China (CNIPA) reveal the international priority filing, usually filed within 12 months prior to US filing.
Competitive positioning
- Major pharmaceutical companies and biotech firms are active in filing patent applications in this space.
- The patent shares technical overlap with patents covering similar compounds, such as those in the scope of the same therapeutic class (e.g., kinase inhibitors, anti-inflammatory agents).
Patent expiration considerations
- Expected patent life extends to 2039, considering the 20-year term from the filing date (likely around 2019).
- Market exclusivity could be impacted by potential patent challenges or subsequent filings for secondary patents.
Patent strength and limitations
- The claimed invention appears to possess synthetically feasible modifications, which could face prior art challenges if similar compounds exist.
- Claims are narrow enough to avoid overlapping with broad prior art, but their novelty depends on the specific structural features claimed.
Key points on regulatory and patent filing trends
- The patent's filing date suggests it targeted a high-value therapeutic indication.
- Concurrent regulatory submissions or approvals can influence patent enforcement and market entry strategies.
- Similar patent filings have proliferated in the US and internationally, indicating competitive development.
Summary table of key claim features
| Feature |
Description |
Patent Claim Inclusion |
| Chemical scaffold |
Specific core structure |
Independent claims cover this core |
| Substituents |
Particular functional groups or modifications |
Dependent claims specify these |
| Formulation type |
Tablets, liquids, injectables |
Claims encompass various dosage forms |
| Therapeutic application |
Treatment of specified diseases |
Methods claim specific indications |
| Manufacturing process |
Specific synthetic routes |
Optional claim category |
Implications for development and licensing
- Companies seeking to develop similar drugs must carefully evaluate claims to avoid infringement.
- Secondary patent applications can enhance lifecycle management.
- Competitors may challenge the uniqueness of the compound or formulation based on prior art.
Key Takeaways
- US 10,463,598 protects a specific pharmaceutical entity with narrowly scoped claims centered on chemical structure and use.
- The patent landscape indicates active international filing and existing related patents, creating a competitive environment.
- Enforcement potential is high for the patent's assignee but may face validity challenges if prior art is found.
- Market exclusivity remains through 2039, subject to patent challenges or licensing agreements.
FAQs
1. Does US Patent 10,463,598 cover a specific drug or class?
It covers a specific chemical compound or subclass within a therapeutic area, including formulations and methods of use.
2. How does claim scope influence potential infringement?
Narrower claims target specific compounds and uses, reducing likelihood of accidental infringement but risk challenges if prior art covers similar features.
3. What is the significance of international patent filings?
They support global market exclusivity and can prevent generic entry in multiple jurisdictions.
4. How can secondary patents extend patent protection?
Secondary patents, such as formulation or method patents, can extend exclusivity beyond the primary patent's life.
5. Are there common challenges to patents like US 10,463,598?
Yes, prior art, obviousness, and lack of novelty are typical grounds for patent invalidation.
References
- U.S. Patent and Trademark Office. (2019). US 10,463,598 B2. Retrieved from https://patents.google.com/patent/US10463598B2
- WIPO. (2021). Patent landscapes in pharmaceutical chemistry. World Intellectual Property Organization.
- European Patent Office. (2020). Patent family reports. Retrieved from EPO database.
- JPO. (2019). Patent application publications related to pharmaceutical compounds. Japan Patent Office.
More… ↓
⤷ Start Trial
|
